Life Saving Drugs Program – Perinatal- or infantile-onset hypophosphatasia (HPP) – Initial application
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
This form includes:
- information about the application process and timelines
- treating physician’s responsibilities
- privacy notice and patient consent
- health professional details
- dosing details
- eligibility requirements and test results
- treating physician’s declaration
- application checklist.